Germie van den Dobbelsteen

Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial

Angela Huttner, Christoph Hatz, Germie van den Dobbelsteen et al. · The Lancet Infectious Diseases · 2017 · 201 citations

Vaccination, Vaccine Safety, Urology +6

Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2–3 and 7–8 years of age

Ester D. de Kleijn, Ronald de Groot, Jerry Labadie et al. · Vaccine · 2000 · 138 citations

Vaccinology, Vaccination, Vaccine Development +7

Superiority of Trans-Oral over Trans-Nasal Sampling in Detecting Streptococcus pneumoniae Colonization in Adults

Krzysztof Trzciński, Debby Bogaert, Anne L. Wyllie et al. · PLoS ONE · 2013 · 126 citations · Full text

Trans-nasal Sampling, Molecular Diagnostic Techniques, Microbial Pathogens +13

Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines

Mark H. Rozenbaum, Elisabeth A. M. Sanders, Albert Jan van Hoek et al. · BMJ · 2010 · 121 citations · Full text

Safety and immunogenicity of a vaccine for extra-intestinal pathogenic Escherichia coli (ESTELLA): a phase 2 randomised controlled trial

Robert W. Frenck, John Ervin, Laurence Chu et al. · The Lancet Infectious Diseases · 2019 · 88 citations

Vaccination, Vaccine Safety, Mucosal Vaccination +6